Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koc-Kan Ho

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|January 28, 2003
Targeting signal transduction with large combinatorial collectionsDouglas S Auld, David Diller, Koc-Kan Ho
Bioorganic & Medicinal Chemistry Letters|June 13, 2013
Synthesis and structure-activity relationship of 2-arylamino-4-aryl-pyrimidines as potent PAK1 inhibitorsYong Xu, Jason M Foulks, Adrianne Clifford, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Synthesis and Biological Evaluation of Pyrazolo[1,5-a]pyrimidine Compounds as Potent and Selective Pim-1 InhibitorsYong Xu, Benjamin G Brenning, Steven G Kultgen, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2012
Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitorsKoc-Kan Ho, K Mark Parnell, Yi Yuan, et al.
Journal of Biomolecular Screening|October 4, 2011
Epigenetic drug discovery: targeting DNA methyltransferasesJason M Foulks, K Mark Parnell, Rebecca N Nix, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2021
Bone-Targeted Bortezomib Inhibits Bortezomib-Resistant Multiple Myeloma in Mice by Providing Higher Levels of Bortezomib in BoneJianguo Tao, Venkat Srinivasan, Xiangjiao Yi, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and hit-to-lead optimization of a novel class of CB1 antagonistsJeffrey J Letourneau, Patrick Jokiel, John Olson, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2013
Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2)Yong Xu, Xiao-Hui Liu, Michael Saunders, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Eicosanoid regulation of debris-stimulated metastasisJianjun Deng, Haixia Yang, Victoria M Haak, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitorsKoc-Kan Ho, Kenneth C Appell, John J Baldwin, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|January 28, 2003
Targeting signal transduction with large combinatorial collectionsDouglas S Auld, David Diller, Koc-Kan Ho
Bioorganic & Medicinal Chemistry Letters|June 13, 2013
Synthesis and structure-activity relationship of 2-arylamino-4-aryl-pyrimidines as potent PAK1 inhibitorsYong Xu, Jason M Foulks, Adrianne Clifford, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Synthesis and Biological Evaluation of Pyrazolo[1,5-a]pyrimidine Compounds as Potent and Selective Pim-1 InhibitorsYong Xu, Benjamin G Brenning, Steven G Kultgen, et al.
Bioorganic & Medicinal Chemistry Letters|December 13, 2012
Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitorsKoc-Kan Ho, K Mark Parnell, Yi Yuan, et al.
Journal of Biomolecular Screening|October 4, 2011
Epigenetic drug discovery: targeting DNA methyltransferasesJason M Foulks, K Mark Parnell, Rebecca N Nix, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2021
Bone-Targeted Bortezomib Inhibits Bortezomib-Resistant Multiple Myeloma in Mice by Providing Higher Levels of Bortezomib in BoneJianguo Tao, Venkat Srinivasan, Xiangjiao Yi, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and hit-to-lead optimization of a novel class of CB1 antagonistsJeffrey J Letourneau, Patrick Jokiel, John Olson, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2013
Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2)Yong Xu, Xiao-Hui Liu, Michael Saunders, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Eicosanoid regulation of debris-stimulated metastasisJianjun Deng, Haixia Yang, Victoria M Haak, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitorsKoc-Kan Ho, Kenneth C Appell, John J Baldwin, et al.
Pageof 3